NasdaqCM - Delayed Quote • USD
NuCana plc (NCNA)
At close: 4:00 PM EDT
After hours: 4:25 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -3.46 | -3.6 | -12.68 | -12.52 |
| Low Estimate | -4.36 | -4.36 | -16.81 | -16.19 |
| High Estimate | -2.49 | -2.8 | -9.03 | -4 |
| Year Ago EPS | -4.67 | -3.11 | -16.5 | -12.68 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -3.42 | -3.98 | -3.13 | -3.17 |
| EPS Actual | -4.67 | -3.11 | -4.05 | -4.36 |
| Difference | -1.25 | 0.87 | -0.92 | -1.19 |
| Surprise % | -36.50% | 21.90% | -29.40% | -37.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -3.46 | -3.6 | -12.68 | -12.52 |
| 7 Days Ago | -3.45 | -3.59 | -12.66 | -12.5 |
| 30 Days Ago | -0.14 | -0.14 | -0.43 | -0.51 |
| 60 Days Ago | -0.11 | -0.12 | -0.37 | -0.42 |
| 90 Days Ago | -0.11 | -0.11 | -0.32 | -0.42 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NCNA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.90% | -- | -- | 2.60% |
| Next Qtr. | -15.80% | -- | -- | 13.40% |
| Current Year | 23.20% | -- | -- | 5.20% |
| Next Year | 1.30% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Oppenheimer: Outperform to Outperform | 4/1/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 11/21/2023 |
| Reiterates | Truist Securities: Buy to Buy | 9/6/2023 |
| Reiterates | Oppenheimer: Outperform to Outperform | 8/18/2023 |
| Reiterates | Oppenheimer: Outperform to Outperform | 5/22/2023 |
| Maintains | Jefferies: Buy | 9/22/2022 |
Related Tickers
TCON TRACON Pharmaceuticals, Inc.
1.7900
-5.29%
ZVSA ZyVersa Therapeutics, Inc.
0.6075
-0.41%
TCBP TC Biopharm (Holdings) Plc
1.5700
+6.80%
ASLN ASLAN Pharmaceuticals Limited
0.4480
-4.68%
ALLR Allarity Therapeutics, Inc.
1.4300
+4.38%
WINT Windtree Therapeutics, Inc.
5.07
-1.65%
NRXP NRx Pharmaceuticals, Inc.
3.1400
+0.64%
PHIO Phio Pharmaceuticals Corp.
0.7060
+5.22%
NBY NovaBay Pharmaceuticals, Inc.
0.0770
-0.39%
KTRA Kintara Therapeutics, Inc.
0.1580
+15.08%